BFRI - Biofrontera Inc.
1.08
0.050 4.630%
Share volume: 75,869
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$1.03
0.05
0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-13-2024 | 03-20-2025 | 05-15-2025 | 11-12-2025 | 03-19-2026 | |
| Assets | ||||||||
| Total Assets | 24.575 M | 21.574 M | 18.516 M | 22.101 M | 16.588 M | 15.415 M | 28.564 M | |
| Current Assets | 20.155 M | 17.471 M | 16.931 M | 20.700 M | 15.332 M | 14.413 M | 18.083 M | |
| Inventories | 6.905 M | 3.946 M | 6.526 M | 6.646 M | 6.527 M | 4.329 M | 1.426 M | |
| Other Current Assets | 5.159 M | 5.159 M | 2.300 M | 2.300 M | 2.300 M | 3.033 M | 686.000 K | |
| Short Term Investments | 23.000 K | 10.000 K | 8.000 K | 7.000 K | 7.000 K | 10.000 K | 9.000 K | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 3.817 M | 4.379 M | 2.873 M | 5.905 M | 1.785 M | 3.417 M | 6.392 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 120.000 K | 101.000 K | 82.000 K | 80.000 K | 59.000 K | 20.000 K | 2.158 M | |
| Other Assets | 4.300 M | 4.002 M | 1.503 M | 1.321 M | 1.197 M | 982.000 K | 8.323 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 24.575 M | 21.574 M | 18.516 M | 22.101 M | 16.588 M | 15.415 M | 28.564 M | |
| Total liabilities | 26.421 M | 10.663 M | 12.986 M | 17.668 M | 16.119 M | 17.996 M | 18.084 M | |
| Total current liabilities | 14.036 M | 9.268 M | 11.032 M | 12.021 M | 10.959 M | 12.553 M | 11.895 M | |
| Accounts Payable | 10.991 M | 8.271 M | 10.362 M | 11.473 M | 10.533 M | 12.246 M | 11.563 M | |
| Other liabilities | 12.385 M | 1.395 M | 1.954 M | 1.549 M | 943.000 K | 981.000 K | 1.600 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 4.098 M | 4.217 M | 4.462 M | 4.589 M | |
| Other liabilities | 12.385 M | 1.395 M | 1.954 M | 1.549 M | 943.000 K | 981.000 K | 1.600 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -5.416 M | 10.911 M | 5.530 M | 4.433 M | 469.000 K | -2.581 M | 10.480 M | |
| Common stock | 104.671 M | 121.255 M | 121.543 M | 121.842 M | 122.081 M | 131.004 M | 138.425 M | |
| Retained earnings | -110.087 M | -110.344 M | -116.013 M | -117.409 M | -121.612 M | -133.585 M | -127.945 M |